Outcome After Surgery for Acute Type A Aortic Dissection With or Without Primary Tear Resection.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
08 2022
Historique:
received: 06 05 2021
revised: 25 08 2021
accepted: 27 09 2021
pubmed: 15 11 2021
medline: 28 7 2022
entrez: 14 11 2021
Statut: ppublish

Résumé

The outcome in patients after surgery for acute type A aortic dissection without replacement of the part of the aorta containing the primary tear is undefined. Data of 1122 patients who underwent surgery for acute type A aortic dissection in 8 Nordic centers from January 2005 to December 2014 were retrospectively analyzed. The patients with primary tear location unfound, unknown, not confirmed, or not recorded (n = 243, 21.7%) were excluded from the analysis. The patients were divided into 2 groups according to whether the aortic reconstruction encompassed the portion of the primary tear (tear resected [TR] group, n = 730) or not (tear not resected [TNR] group, n = 149). The restricted mean survival time ratios adjusted for patient characteristics and surgical details between the groups were calculated for all-cause mortality and aortic reoperation-free survival. The median follow-up time was 2.57 (interquartile range, 0.53-5.30) years. For the majority of the patients in the TR group, the primary tear was located in the ascending aorta (83.6%). The reconstruction encompassed both the aortic root and the aortic arch in 7.4% in the TR group as compared with 0.7% in the TNR patients (P < .001). There were no significant differences in all-cause mortality (adjusted restricted mean survival time ratio, 1.01; 95% confidence interval, 0.92-1.12; P = .799) or reoperation-free survival (adjusted restricted mean survival time ratio, 0.98; 95% confidence interval, 0.95-1.02; P = .436) between the TR and TNR groups. Primary tear resection alone does not determine the midterm outcome after surgery for acute type A aortic dissection.

Sections du résumé

BACKGROUND
The outcome in patients after surgery for acute type A aortic dissection without replacement of the part of the aorta containing the primary tear is undefined.
METHODS
Data of 1122 patients who underwent surgery for acute type A aortic dissection in 8 Nordic centers from January 2005 to December 2014 were retrospectively analyzed. The patients with primary tear location unfound, unknown, not confirmed, or not recorded (n = 243, 21.7%) were excluded from the analysis. The patients were divided into 2 groups according to whether the aortic reconstruction encompassed the portion of the primary tear (tear resected [TR] group, n = 730) or not (tear not resected [TNR] group, n = 149). The restricted mean survival time ratios adjusted for patient characteristics and surgical details between the groups were calculated for all-cause mortality and aortic reoperation-free survival. The median follow-up time was 2.57 (interquartile range, 0.53-5.30) years.
RESULTS
For the majority of the patients in the TR group, the primary tear was located in the ascending aorta (83.6%). The reconstruction encompassed both the aortic root and the aortic arch in 7.4% in the TR group as compared with 0.7% in the TNR patients (P < .001). There were no significant differences in all-cause mortality (adjusted restricted mean survival time ratio, 1.01; 95% confidence interval, 0.92-1.12; P = .799) or reoperation-free survival (adjusted restricted mean survival time ratio, 0.98; 95% confidence interval, 0.95-1.02; P = .436) between the TR and TNR groups.
CONCLUSIONS
Primary tear resection alone does not determine the midterm outcome after surgery for acute type A aortic dissection.

Identifiants

pubmed: 34774491
pii: S0003-4975(21)01846-4
doi: 10.1016/j.athoracsur.2021.09.067
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

492-501

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Mikko Uimonen (M)

Tampere University Heart Hospital, Tampere University, Tampere, Finland; Tampere University, Tampere, Finland.

Christian Olsson (C)

Karolinska University Hospital, Stockholm, Sweden.

Anders Jeppsson (A)

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.

Arnar Geirsson (A)

Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden; Division of Cardiac Surgery, Yale School of Medicine, New Haven, Connecticut.

Raphaelle Chemtob (R)

Department of Cardiovascular Surgery, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.

Ahmad Khalil (A)

Aarhus University Hospital, Aarhus, Denmark.

Vibeke Hjortdal (V)

Aarhus University Hospital, Aarhus, Denmark.

Emma C Hansson (EC)

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.

Shahab Nozohoor (S)

Department of Cardiothoracic Surgery, Skåne University Hospital, Clinical Sciences, Lund University, Lund, Sweden.

Igor Zindovic (I)

Department of Cardiothoracic Surgery, Skåne University Hospital, Clinical Sciences, Lund University, Lund, Sweden.

Jarmo Gunn (J)

Turku University Hospital, Turku, Finland.

Anders Wickbom (A)

Örebro University Hospital, Örebro, Sweden.

Anders Ahlsson (A)

Karolinska University Hospital, Stockholm, Sweden.

Tomas Gudbjartsson (T)

Landspitali University Hospital, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Ari Mennander (A)

Tampere University Heart Hospital, Tampere University, Tampere, Finland; Tampere University, Tampere, Finland. Electronic address: ari.mennander@sydansairaala.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH